Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

NCT06891157 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Chidamide
R-CHOP Chemotherapy
DLBCL - Diffuse Large B Cell Lymphoma
Double-expressor Lymphoma (DEL)

Interventions

DRUG: Chidamide plus R-CHOP

Sponsor

The First Affiliated Hospital with Nanjing Medical University